Oral Health-Related Quality of Life Using EORTC QLQ-H&N35 in Head and Neck Cancer Survivors Within the First Year Following Treatment: a Cross-Sectional Study in Egypt

Launched by AIN SHAMS UNIVERSITY · Mar 23, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the quality of life related to oral health in survivors of head and neck cancer in Egypt, specifically within the first year after their treatment. Researchers want to understand how treatments like surgery, radiation, and chemotherapy affect patients' oral health and overall well-being. They will collect information through questionnaires and clinical assessments at Ahmed Maher Teaching Hospital, focusing on factors like personal habits and the severity of any mouth-related side effects.

To participate, individuals must be between 65 and 74 years old, have completed their cancer treatment within the last year, and be able to complete a specific questionnaire. Participants should also have at least one molar and one central incisor to ensure proper oral health assessment. The study aims to gather insights that could improve oral care for head and neck cancer survivors, helping to enhance their quality of life. If selected, participants can expect to share their experiences and contribute to important research that may benefit future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • (HNC).
• • Completed cancer treatment (surgery, radiotherapy, and/or chemotherapy) within the past 12 months.
• • Attending routine follow-up visits at Ahmed Maher Teaching Hospital (AMTH), Egypt.
• • Able to communicate and complete the EORTC QLQ-H\&N35 questionnaire.
• • Presence of at least one molar and one central incisor in both upper and lower dentition (for oral hygiene assessment).
• • Provided written informed consent to participate in the study.
• Exclusion Criteria:
• • Patients with cognitive impairment or severe mental illness affecting their ability to respond to the questionnaire.
• • Patients with debilitating conditions (e.g., terminal illness, bedridden status).
• • Trismus (mouth opening \<20mm) preventing oral examination.
• • Patients who decline to participate or withdraw consent.
• • Patients with incomplete medical records or loss to follow-up.